Association of APOE polymorphisms with disease severity in MS is limited to women
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read the article by Kantarci et al. with great interest. It examined the sex-specific association of APOE polymorphisms with disease severity in multiple sclerosis (MS).1 Sex specificity is important and has not been previously addressed. We recently analyzed and described APOE polymorphisms in relation to MS susceptibility, disease characteristics (including age at onset and onset type), disease severity (progression index, time to reach Expanded Disability Status Scale [EDSS] 6), and MRI findings (lesion volumes and atrophy measures) in a cohort of 408 MS patients, but did not focus on sex specificity.2
In an attempt to validate the findings by Kantarci et al., we re-analyzed our data applying similar methods. Our cohort included 250 women and 158 men, mean age at onset (± SD) 32.3 ± 9.5 years, mean disease duration 13.4 ± 8.0 years, median time to EDSS 6 9.2 (IQR 5.4 to 14.0) years, and 39% relapsing remitting, 39% secondary progressive, and 22% primary progressive. Genotype …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Fabricio Ferreira de Oliveira and Dr. Alan Cronemberger Andrade
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosisL. Truyen, J. H.T.M. van Waesberghe, M.A.A. van Walderveen et al.Neurology, December 01, 1996 -
Articles
Primary and transitional progressive MSA clinical and MRI cross-sectional studyV.L. Stevenson, D.H. Miller, M. Rovaris et al.Neurology, March 01, 1999 -
Articles
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophyA. van der Walt, J. Stankovich, M. Bahlo et al.Neurology, September 28, 2009 -
Articles
APOE epsilon variation in multiple sclerosis susceptibility and disease severitySome answersR. M. Burwick, P. P. Ramsay, J. L. Haines et al.Neurology, May 08, 2006